mCRP as a Biomarker of Adult-Onset Still’s Disease: Quantification of mCRP by ELISA

202220 citationsJournal Articlegold Open Access

Authors

Chitose Fujita · The Japan-Multinational Trial Organization

Yasuo Sakurai · Canon (Japan)

Yuki Yasuda · Canon (Japan)

Rino Homma · Canon Medical Systems Corporation (Japan)

Chenglong Huang · Kitano Hospital

Masaaki Fujita · Kitano Hospital

Abstract

The plasma mCRP levels are elevated in some autoimmune diseases, particularly AOSD. The plasma mCRP levels may therefore be a potentially useful biomarker for AOSD.

Topics & Keywords

Autoimmune and Inflammatory Disorders Research Inflammasome and immune disorders Kawasaki Disease and Coronary Complications

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Immunology

Volume 13, pp. 938173-938173

DOI: 10.3389/fimmu.2022.938173

Field-Weighted Citation Impact: 3.05